van Bohemen, Samuel J. http://orcid.org/0000-0001-9620-4099
Rogers, Jeffrey M.
Boughton, Philip C.
Clarke, Jillian L.
Valderrama, Joaquin T.
Kyme, Andre Z.
Article History
Received: 23 September 2022
Revised: 11 January 2023
Accepted: 22 January 2023
First Online: 9 February 2023
Change Date: 21 February 2023
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: Samuel J. van Bohemen is a co-founder and shareholder of nuroflux Pty Ltd. Philip C. Boughton is a shareholder of nuroflux Pty Ltd. nuroflux Pty Ltd is the applicant of a published PCT application (WO2021/077154A1) for the described method of monitoring changes in CBF. Samuel J. van Bohemen, Philip C. Boughton and Andre Z. Kyme are listed as inventors on the published PCT application.
: All experimental procedures were conducted in accordance with an approved human ethics protocol (USyd 2019/1008).
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human subjects provided informed consent for publication of the images in Fig. InternalRef removedb and Fig. InternalRef removedd.